{
  "1": {
    "patient_diagnosis": "NET des Dünndarms mit Lymphknoten und Lebermetastasen (ED 2015)\nKoloskopie bei unklaren abdominellen Beschwerden 06/2015: Tumor im Ileum 25 cm oberhalb der Ileozökalklappe. G1 NET.\n07/2015 CT staging Thorax/Abdomen: Primärtumor des Ileums 40 x 40 x 70 mm. V.a. Lymphknotenmetastasen lokoregionär. V.a. Lebermetastasen in Segment VI und VIII.\n\n07/2015 Resektion der Lebermetastasen in Segment VI und Ablation der Läsion in Segment VIII. Hemicolektomie rechts und Ileumteilresektion mit Lymphadenektomie.\n01/2017 V.a. neue Lebermetastase\n02/2017 Start Somatoline\n02/2018 CT Abdomen: stable disease\n03/2019 CT Abdomen: V.a. gering progrediente Lebermetastasen. ",
    "match_count": 20,
    "top_matches": [
      {
        "nct_id": "NCT00428220",
        "title": "A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.",
        "phase": "NA",
        "status": "COMPLETED",
        "relevance": "Relevance: 29 - NET condition match; Small intestine NET match; Liver metastases match; Completed study"
      },
      {
        "nct_id": "NCT01578239",
        "title": "A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours",
        "phase": "PHASE3",
        "status": "COMPLETED",
        "relevance": "Relevance: 28 - NET condition match; Small intestine NET match; Completed study; PHASE3 study; 4 publications"
      },
      {
        "nct_id": "NCT03736720",
        "title": "Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin",
        "phase": "PHASE2",
        "status": "TERMINATED",
        "relevance": "Relevance: 27 - NET condition match; Small intestine NET match; Liver metastases match; PHASE2 study"
      },
      {
        "nct_id": "NCT00171873",
        "title": "Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut",
        "phase": "PHASE3",
        "status": "COMPLETED",
        "relevance": "Relevance: 26 - NET condition match; Small intestine NET match; Completed study; PHASE3 study"
      },
      {
        "nct_id": "NCT00427349",
        "title": "AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 26 - NET condition match; Small intestine NET match; Completed study; PHASE2 study"
      }
    ]
  },
  "2": {
    "patient_diagnosis": "NET des Dünndarms mit Lymphknoten und Lebermetastasen (ED 2015)\nKoloskopie bei unklaren abdominellen Beschwerden 06/2015: Tumor im Ileum 25 cm oberhalb der Ileozökalklappe. G3 NET, Ki67 48%.\n07/2015 CT staging Thorax/Abdomen: Primärtumor des Ileums 40 x 40 x 70 mm. V.a. Lymphknotenmetastasen lokoregionär. V.a. Lebermetastasen in Segment VI und VIII.\n\n07/2015 Hemicolektomie rechts und Ileumteilresektion mit Lymphadenektomie.",
    "match_count": 20,
    "top_matches": [
      {
        "nct_id": "NCT00428220",
        "title": "A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.",
        "phase": "NA",
        "status": "COMPLETED",
        "relevance": "Relevance: 29 - NET condition match; Small intestine NET match; Liver metastases match; Completed study"
      },
      {
        "nct_id": "NCT01578239",
        "title": "A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours",
        "phase": "PHASE3",
        "status": "COMPLETED",
        "relevance": "Relevance: 28 - NET condition match; Small intestine NET match; Completed study; PHASE3 study; 4 publications"
      },
      {
        "nct_id": "NCT03736720",
        "title": "Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin",
        "phase": "PHASE2",
        "status": "TERMINATED",
        "relevance": "Relevance: 27 - NET condition match; Small intestine NET match; Liver metastases match; PHASE2 study"
      },
      {
        "nct_id": "NCT00171873",
        "title": "Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut",
        "phase": "PHASE3",
        "status": "COMPLETED",
        "relevance": "Relevance: 26 - NET condition match; Small intestine NET match; Completed study; PHASE3 study"
      },
      {
        "nct_id": "NCT00427349",
        "title": "AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 26 - NET condition match; Small intestine NET match; Completed study; PHASE2 study"
      }
    ]
  },
  "3": {
    "patient_diagnosis": "NET des Dünndarms mit Lymphknoten und Lebermetastasen (ED 2015)\nKoloskopie bei unklaren abdominellen Beschwerden 06/2015: Tumor im Ileum 25 cm oberhalb der Ileozökalklappe. G2 NET.\n07/2015 CT staging Thorax/Abdomen: Primärtumor des Ileums 40 x 40 x 70 mm. V.a. Lymphknotenmetastasen lokoregionär. V.a. Lebermetastasen in Segment VI und VIII.\n\n07/2015 DOTATOC PET: geringe Speicherung der Leberläsionen.\n07/2015 Hemicolektomie rechts und Ileumteilresektion mit Lymphadenektomie.",
    "match_count": 20,
    "top_matches": [
      {
        "nct_id": "NCT00428220",
        "title": "A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.",
        "phase": "NA",
        "status": "COMPLETED",
        "relevance": "Relevance: 29 - NET condition match; Small intestine NET match; Liver metastases match; Completed study"
      },
      {
        "nct_id": "NCT01578239",
        "title": "A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours",
        "phase": "PHASE3",
        "status": "COMPLETED",
        "relevance": "Relevance: 28 - NET condition match; Small intestine NET match; Completed study; PHASE3 study; 4 publications"
      },
      {
        "nct_id": "NCT03736720",
        "title": "Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin",
        "phase": "PHASE2",
        "status": "TERMINATED",
        "relevance": "Relevance: 27 - NET condition match; Small intestine NET match; Liver metastases match; PHASE2 study"
      },
      {
        "nct_id": "NCT00171873",
        "title": "Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut",
        "phase": "PHASE3",
        "status": "COMPLETED",
        "relevance": "Relevance: 26 - NET condition match; Small intestine NET match; Completed study; PHASE3 study"
      },
      {
        "nct_id": "NCT00427349",
        "title": "AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 26 - NET condition match; Small intestine NET match; Completed study; PHASE2 study"
      }
    ]
  },
  "4": {
    "patient_diagnosis": "NET des Pankreas mit Lymphknoten und Lebermetastasen (ED 2015)\nCT bei unklaren abdominellen Beschwerden 06/2015: Tumor im Pankreas. G2 NET.\n07/2015 CT staging Thorax/Abdomen: Primärtumor des Pankreas 20 x 40 x 30 mm. V.a. Lymphknotenmetastasen lokoregionär. V.a. Lebermetastasen in Segment VI und VIII.\n\n08/2015 Start Somatuline\n06/2016 DOTATOC PET: Progress der Lebermetastasen, starke Speicherung der Leberläsionen.",
    "match_count": 20,
    "top_matches": [
      {
        "nct_id": "NCT00113360",
        "title": "RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 32 - NET condition match; Pancreatic NET match; Liver metastases match; Completed study; PHASE2 study"
      },
      {
        "nct_id": "NCT02402062",
        "title": "A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 32 - NET condition match; Pancreatic NET match; Liver metastases match; Completed study; PHASE2 study"
      },
      {
        "nct_id": "NCT01010126",
        "title": "Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 32 - NET condition match; Pancreatic NET match; Liver metastases match; Completed study; PHASE2 study"
      },
      {
        "nct_id": "NCT01169649",
        "title": "Study of MK-2206 in Patients With Metastatic Neuroendocrine Tumors (NET)",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 32 - NET condition match; Pancreatic NET match; Liver metastases match; Completed study; PHASE2 study"
      },
      {
        "nct_id": "NCT00454363",
        "title": "Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 32 - NET condition match; Pancreatic NET match; Liver metastases match; Completed study; PHASE2 study"
      }
    ]
  },
  "5": {
    "patient_diagnosis": "NET des Pankreas mit Lymphknoten und Lebermetastasen (ED 2015)\nCT bei unklaren abdominellen Beschwerden 06/2015: Tumor im Pankreas. G2 NET.\n07/2015 CT staging Thorax/Abdomen: Primärtumor des Pankreas 20 x 40 x 30 mm. V.a. Lymphknotenmetastasen lokoregionär. V.a. Lebermetastasen in Segment VI und VIII.\n\n06/2015 DOTATOC PET: starke Speicherung der Läsionen.",
    "match_count": 20,
    "top_matches": [
      {
        "nct_id": "NCT00113360",
        "title": "RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 32 - NET condition match; Pancreatic NET match; Liver metastases match; Completed study; PHASE2 study"
      },
      {
        "nct_id": "NCT02402062",
        "title": "A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 32 - NET condition match; Pancreatic NET match; Liver metastases match; Completed study; PHASE2 study"
      },
      {
        "nct_id": "NCT01010126",
        "title": "Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 32 - NET condition match; Pancreatic NET match; Liver metastases match; Completed study; PHASE2 study"
      },
      {
        "nct_id": "NCT01169649",
        "title": "Study of MK-2206 in Patients With Metastatic Neuroendocrine Tumors (NET)",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 32 - NET condition match; Pancreatic NET match; Liver metastases match; Completed study; PHASE2 study"
      },
      {
        "nct_id": "NCT00454363",
        "title": "Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer",
        "phase": "PHASE2",
        "status": "COMPLETED",
        "relevance": "Relevance: 32 - NET condition match; Pancreatic NET match; Liver metastases match; Completed study; PHASE2 study"
      }
    ]
  }
}